Healthcare provider profile · identity verified

Frederick U Torio, MD

Internal Medicine · WESTFIELD, MA · NPI 1295726966

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	608	170
Amlodipine Besylate	Amlodipine Besylate	295	89
Lisinopril	Lisinopril	290	86
Omeprazole	Omeprazole	220	63
Gabapentin	Gabapentin	176	41
Albuterol Sulfate Hfa	Albuterol Sulfate	171	39
Levothyroxine Sodium	Levothyroxine Sodium	170	48
Metoprolol Succinate	Metoprolol Succinate	166	52
Tamsulosin Hcl	Tamsulosin Hcl	157	51
Losartan Potassium	Losartan Potassium	139	46
Rosuvastatin Calcium	Rosuvastatin Calcium	127	40
Hydrochlorothiazide	Hydrochlorothiazide	108	33
Simvastatin	Simvastatin	106	35
Metformin Hcl	Metformin Hcl	103	31
Fluticasone Propionate	Fluticasone Propionate	102	28
Metformin Hcl Er	Metformin Hcl	100	28
Trulicity	Dulaglutide	100	17
Eliquis	Apixaban	96	27
Trazodone Hcl	Trazodone Hcl	93	26
Lorazepam	Lorazepam	87	34
Allopurinol	Allopurinol	85	27
Furosemide	Furosemide	84	30
Ozempic	Semaglutide	79	14
Januvia	Sitagliptin Phosphate	75	19
Metoprolol Tartrate	Metoprolol Tartrate	75	22
Glimepiride	Glimepiride	73	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	20
Pantoprazole Sodium	Pantoprazole Sodium	64	19
Sertraline Hcl	Sertraline Hcl	62	23
Olmesartan Medoxomil	Olmesartan Medoxomil	61	18
Celecoxib	Celecoxib	54	11
Ventolin Hfa	Albuterol Sulfate	48	suppressed
Pravastatin Sodium	Pravastatin Sodium	47	13
Carvedilol	Carvedilol	46	15
Chlorthalidone	Chlorthalidone	44	11
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	12
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Farxiga	Dapagliflozin Propanediol	39	12
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Pregabalin	Pregabalin	39	14
Bupropion Xl	Bupropion Hcl	37	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	17
Ipratropium Bromide	Ipratropium Bromide	36	19
Synthroid	Levothyroxine Sodium	35	suppressed
Atenolol	Atenolol	34	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	34	suppressed
Meloxicam	Meloxicam	34	11
Tizanidine Hcl	Tizanidine Hcl	34	12
Valsartan	Valsartan	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	12
Jardiance	Empagliflozin	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Baclofen	Baclofen	29	12
Finasteride	Finasteride	29	suppressed
Tramadol Hcl	Tramadol Hcl	28	12
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Fluvoxamine Maleate Er	Fluvoxamine Maleate	26	suppressed
Prednisone	Prednisone	26	17
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Torsemide	Torsemide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Glipizide	Glipizide	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Unifine Pentips	Pen Needle, Diabetic	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Famotidine	Famotidine	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Topiramate	Topiramate	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error